BlackRock
AGL icon

BlackRock’s Agilon Health AGL Stock Holding History

BlackRock’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123M Buy
1,146,520
+273,356
+31% +$17.9M ﹤0.01% 2100
2026
Q1 		$6.91M Sell
873,164
-31,438
-3% -$508K ﹤0.01% 3703
2025
Q4 		$15.6M Sell
904,602
-63,303
-7% -$1.23M ﹤0.01% 3226
2025
Q3 		$24.9M Sell
967,905
-23,020
-2% -$870K ﹤0.01% 2948
2025
Q2 		$57M Buy
990,925
+1,459
+0.1% +$117K ﹤0.01% 2374
2025
Q1 		$107M Buy
989,466
+36,731
+4% +$3.2M ﹤0.01% 1945
2024
Q4 		$45.3M Sell
952,735
-1,677
-0.2% -$101K ﹤0.01% 2508
2024
Q3 		$93.8M Buy
954,412
+25,607
+3% +$3.31M ﹤0.01% 2128
2024
Q2 		$152M Buy
928,805
+369,116
+66% +$52.6M ﹤0.01% 1778
2024
Q1 		$85.4M Buy
559,689
+10,636
+2% +$1.77M ﹤0.01% 2144
2023
Q4 		$172M Buy
549,053
+11,190
+2% +$4.05M ﹤0.01% 1743
2023
Q3 		$239M Buy
537,863
+21,203
+4% +$9.58M 0.01% 1421
2023
Q2 		$224M Buy
516,660
+167,783
+48% +$94.3M 0.01% 1500
2023
Q1 		$207M Buy
348,877
+1,433
+0.4% +$803K 0.01% 1509
2022
Q4 		$140M Buy
347,444
+4,801
+1% +$2.25M ﹤0.01% 1777
2022
Q3 		$201M Buy
342,643
+59,212
+21% +$35.5M 0.01% 1470
2022
Q2 		$155M Buy
283,431
+32,280
+13% +$16.3M 0.01% 1720
2022
Q1 		$159M Sell
251,151
-67,494
-21% -$34.8M ﹤0.01% 1823
2021
Q4 		$215M Sell
318,645
-17,524
-5% -$10.7M 0.01% 1685
2021
Q3 		$220M Buy
336,169
+37,701
+13% +$32.2M 0.01% 1640
2021
Q2 		$303M Buy
+298,468
New +$261M 0.01% 1464

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock's AGL Position: Q2 2026 in Review

BlackRock increased its Agilon Health (AGL) stake by 31% in Q2 2026, buying an estimated $17.9M and bringing the position to 1,146,520 shares worth $123M. The position accounts for ﹤0.01% of the portfolio, ranked #2100.

BlackRock first reported a position in AGL in Q2 2021 and has held it in 21 quarters since. The position peaked at $303M in Q2 2021. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • BlackRock held 1,146,520 shares of Agilon Health worth $123M as of Q2 2026.
  • BlackRock bought 273,356 Agilon Health shares in Q2 2026, an estimated $17.9M.
  • Agilon Health made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2100 holding.
  • BlackRock first reported a position in Agilon Health in Q2 2021 and has held it in 21 quarters since.
  • BlackRock's Agilon Health position peaked at $303M in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.